$47.53
0.02[0.04%]
At close: Apr 19
$47.53
0[0.00%]
After Hours: 4:00PM EDT
Apellis Pharmaceuticals
(NASDAQ:APLS)Apellis Pharmaceuticals Stock (NASDAQ:APLS), Quotes and News Summary
Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.
| Open | $47.520 |
| Close | $47.530 |
| Volume / Avg. | 1.179M / 1.376M |
| Day Range | 46.530 - 48.190 |
| 52 Wk Range | 19.830 - 94.750 |
| Market Cap | $5.731B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 29 |
| Short Interest | 10.05% |
| Days to Cover | 9.5 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Apellis Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Apellis Pharmaceuticals (APLS) stock?
You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.
Who are Apellis Pharmaceuticals's (APLS) competitors?
Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the target price for Apellis Pharmaceuticals (APLS) stock?
The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by Wedbush on Wednesday, April 17, 2024. The analyst firm set a price target for 57.00 expecting APLS to rise to within 12 months (a possible 19.92% upside). 70 analyst firms have reported ratings in the last year.
Current Stock Price for Apellis Pharmaceuticals (APLS)?
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $47.53 last updated Today at April 19, 2024 at 4:00 PM EDT.
Does Apellis Pharmaceuticals (APLS) pay a dividend?
There are no upcoming dividends for Apellis Pharmaceuticals.
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Apellis Pharmaceuticals (APLS) going to split?
There is no upcoming split for Apellis Pharmaceuticals.
What sector and industry does Apellis Pharmaceuticals (APLS) operate in?
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.